acnes induced the secretion of interleukin-1a (IL-1a), tumor necrosis factor-a (TNF-a), and IL-8 from human keratinocytes. The phosphorylation of p38 (phospho-p38) and the secretion of cytokines induced by P. acnes in cultured keratinocytes were inhibited by SB203580, a p38a/b inhibitor. Furthermore, SCIO-469, a selective inhibitor of p38a, showed similar effects in cultured keratinocytes. Topical treatment of SCIO-469 inhibited the P. acnes-induced phospho-p38 and cytokine secretion in human epidermal equivalents.
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INTRODUCTION
Propionibacterium acnes contributes to inflammatory acne by stimulating keratinocytes, sebocytes, and immune cells to produce multiple proinflammatory cytokines such as interleukin (IL)-1a, tumor necrosis factor (TNF)-a, and chemokines (e.g., IL-8), which, in turn, attract neutrophils and mononuclear cells to the pilosebaceous unit [1] [2] [3] [4] [5] [6] [7] [8] . P. acnes can also directly cause tissue injury [9] [10] [11] [12] [13] . In addition, P. acnes can activate inflammasomes and induce IL-1b secretion from monocytes [14, 15] . Toll-like receptors (TLRs) and nuclear factor kappa B (NF-jB) are involved in P. acnes-induced inflammation [4, [16] [17] [18] [19] . Microbial products and cytokines act through the Toll-like, IL-1, and TNF receptor families to activate mitogen-activated protein kinases (MAPKs), leading to the activation of NF-jB [20] [21] [22] [23] [24] [25] . Very few studies have investigated which MAPK may mediate the proinflammatory response [26, 27] .
There are three major groups of MAPKs: the extracellular signal-related kinases (ERK1/2), the c-Jun N-terminal kinases (JNK1/2), and the p38 MAPKs (a, b, c, and d) [20, [28] [29] [30] [31] [32] [33] [34] [35] [36] . ERKs are predominantly activated by mitogenic factors, while JNK and p38 are preferentially activated by proinflammatory cytokines and stressinducing stimuli [33] . For p38 MAPKs, a and b are ubiquitously expressed, whereas c and d are expressed in more restricted patterns [37] . In human keratinocytes, p38a and b are involved in responses to stress and proinflammatory cytokines, while p38d has been implicated in keratinocyte differentiation [38] . p38 MAPKs have been implicated in inflammatory disease pathways such as psoriasis, asthma, and Crohn's disease and the p38a kinase might play a central role in inflammation [35, 39] .
Inhibitors of p38 serve as valuable tools for elucidating the role of that enzyme in inflammatory responses. SB203580 is an inflammatory cytokine inhibitor that blocks both p38a and p38b kinase activities [37] .
SCIO-469 is a relatively selective inhibitor of the a isoform of p38 [40] . Topical administration of SCIO-469 reduced acute skin inflammation in guinea pigs [41] . p38 regulates the production of inflammatory mediators that stimulate leukocyte recruitment and activation [42] .
Many of these mediators (e.g., IL-1, TNF-a, and IL-8) are secreted by keratinocytes in response to P. acnes [5] [6] [7] . Thus, the purpose of this study was to evaluate whether the P. acnes-induced proinflammatory cytokine release is mediated by P. acnes-induced activation of p38 mitogenactivated protein kinase (p38 MAPK or p38) in human keratinocytes. [43] .
METHODS
The immunohistochemical assessment was done by visually assessing the intensity of the signal (brown color) in acne lesions vs healthy skin. A representative image of acne lesions was chosen with strong (dark brown color) nuclear staining of phospho-p38 and that of healthy skin was chosen with no/weak (no color/light brown color) nuclear staining of phospho-p38 in follicular and perifollicular epidermal keratinocytes.
Human Epidermal Equivalents
Human epidermal equivalents were purchased from MatTek Company (Asland, MA, USA).
Upon receipt, human epidermal equivalents were incubated in EPI-100-ASY antibiotic-free MatTek assay medium overnight and then changed to KGM for another overnight incubation before topical treatment.
Enzyme-Linked Immunosorbent Assay (ELISA)
The protocol was adapted from Graham et al. [14] with modifications. In brief, human primary keratinocytes were pre-incubated for 1 h with either p38 inhibitors or with vehicle, and the treatments were stopped. The keratinocytes were then exposed to stationary-phase P. acnes (at a ratio of P. acnes to keratinocytes of 50:1) and were co-cultured for 16 h at 37°C. As for human epidermal equivalents, they were topically treated with either vehicle or the p38 inhibitors for 2 h, followed by changing the medium to KGM in either absence or presence of live stationary-phase P. acnes at 10 8 CFU/mL for 16 h. After incubation, the supernatants were analyzed using Beadlyte Ò human multi-cytokine ELISA beadmaster TM Assays (Upstate Cell Signaling Solution, Lake Placid, NY, USA).
Results are presented as the mean ± SD of eight replicate wells for keratinocytes or of two equivalents, in which triplicates were collected from each equivalent. Half-maximal inhibitory concentrations (IC 50 's) were calculated using SigmaPlot Version 9.0 (Csystat Software Inc., San Jose, CA, USA).
Lactate dehydrogenase (LDH) assays (G-
Biosciences, St. Louis, MO, USA) were performed in all the supernatants to ensure no cytotoxicity occurred in the cells under the experimental conditions.
Western Analysis
Activation of p38, ERK1/2, and JNK in human primary keratinocytes or epidermal equivalents was evaluated by Western blot using phospho-specific antibodies, and was normalized to the total level of the relevant proteins using anti-p38, anti-ERK1/2, and 
RESULTS

Activation of p38 in Human Acne Lesions
Phospho-p38 expression was detected in all five acne tissue samples with a nuclear localization. A representative image of healthy skin shows mainly diffuse cytoplasmic staining of phospho-p38 in both epidermal and dermal cells (Fig. 1a) , and weak nuclear staining in some hair follicle cells (Fig. 1b) . In contrast, markedly increased level of phospho-p38 was observed in the inflammatory acne lesion (Fig. 1c) . The phospho-p38 was mostly confined to the nuclei of follicular and perifollicular epidermal keratinocytes (Fig. 1d) .
Propionibacterium acnes Induces a TimeDependent Activation of MAPKs in Keratinocytes
Stationary-phase P. acnes stimulated rapid (within 5 min) phosphorylation of both p38 (phospho-p38) and ERK1/2 (phospho-ERK1/2), with peaks at 15 min (Fig. 2a) . There was up to a sevenfold increase in phosphorylation of p38 and ERK1/2, compared to untreated (Fig. 2b,   c ). An additional activation peak of phospho-ERK1/2 occurred between 2 and 4 h (approximately sixfold increase; Fig. 2a, c) . P. acnes also induced relatively slow but sustained phosphorylation of JNK1/2 (phospho-JNK1/2); the maximum increase was approximately fourfold between 2 and 8 h (Fig. 2a, d ). These results show that viable P. acnes induced the activation of multiple MAPK pathways in cultured human keratinocytes.
Propionibacterium acnes-Induced
Phospho-p38 and Secretion of Cytokines are Suppressed by SB203580
Pretreatment of the keratinocytes with SB203580 at 10 and 25 lM reduced P. acnes-induced phospho-p38 to basal levels (Fig. 3a) . Stationaryphase P. acnes stimulated the production of TNF-a (Fig. 3b) and IL-8 (Fig. 3c) . Pretreatment of keratinocytes with SB203580 significantly suppressed P. acnes-induced secretion of TNF-a and IL-8 (Fig. 3b, c , both p\0.005). Pretreatment of the keratinocytes with SCIO-469 inhibited P. acnes-induced phospho-p38 in a dose-dependent fashion with a 50% inhibition at 16-80 nM, and complete inhibition was observed between 0.4 and 2 lM (Fig. 4a) . There was no inhibition but upregulation of P. acnes induced either phospho-ERK1/2 or phospho-JNK1/2 (Fig. 4a ).
Stationary-phase P. acnes stimulated the production of TNF-a (Fig. 4b, p\0 .005), IL-8 (Fig. 4c, p\0 .005), and IL-1a (Fig. 4d, 
p\0.005). Pretreatment of keratinocytes with SCIO-469 dose-dependently inhibited P. acnes-
induced TNF-a secretion with an IC 50 of 79 nM (Fig. 4b) . SCIO-469 also significantly suppressed IL-8 and IL-1a secretion (Fig. 4c, d ), but the degree of suppression was less for IL-8 and IL-1a than that observed for TNF-a. Fig. 5a, b) . Topical SCIO-469 at 4-100 lM inhibited P. acnes-induced phosphop38 dose-dependently (Fig. 5a ) as compared to P. acnes-induced plus vehicle-treated control (Veh ? PA). In addition, topical SCIO-469 suppressed P. acnes-induced secretion of both TNF-a and IL-8 significantly (p\0.005) at 20 and 100 lM (Fig. 5b, c) . As expected, viable P.
acnes also induced secretion of IL-1a in the skin equivalents. Inhibition of IL-1a by topical SCIO-469 was also observed, but with no obvious dose-response curve (data not shown).
DISCUSSION
In this study, p38 MAPK was highly activated in the inflammatory acne lesions compared to normal skin. Using small molecule p38 inhibitors, it was further demonstrated that these compounds not only suppressed P. acnesinduced phosphorylation of p38 in vitro, but also decreased P. acnes-induced proinflammatory cytokine and chemokine production in keratinocytes in vitro. These data suggest that activation of p38 by P. acnes may be one of the contributors to the clinical development of inflammatory acne.
The current study was a pilot investigation on the histological and histochemical skin changes showing there was activation of p38 signaling in inflammatory acne lesions. A limitation of the current study was the small number of acne biopsies that could be obtained and evaluated. Obtaining biopsies of acne lesions was challenging which limits the extrapolation of the results. In addition, this study evaluated p38 only in inflammatory acne lesions; it could be interesting to examine p38 activation in early lesional samples such as comedones.
Exposure of keratinocytes to P. acnes induced the activation of multiple MAPK pathways. SB203580, a p38a/b inhibitor, inhibited acnes-induced phospho-p38 in a dose-dependent fashion, suggesting the major isoform activated by P. acnes in keratinocytes is p38a. However, when phospho-p38 was blocked by SCIO-469, a concomitant upregulation of phospho-ERK1/2 and phospho-JNK1/2 was observed. This observation was consistent with previous findings [40, 44] . Similar data were also reported in a wound-healing model and a conditional p38a knock-out mouse model [45, 46] . [47] [48] [49] . TNFa may drive the early stage of inflammatory acne lesions [5] . IL-8 is a potent chemotactic agent for neutrophils, and both IL-8 and neutrophils are commonly found in high levels in inflammatory acne lesions [17, 50] .
IL-8-induced chemotaxis of neutrophils may be activated by endogenous or exogenous (e.g., bacterial) factors to release lysosomal enzymes that can degrade the follicular epithelium, leading to further inflammation [51] . In lipopolysaccharide (LPS)-stimulated human monocytes, p38a MAPK was the molecular target for the biosynthesis of TNF-a and IL-1 [20, 21] . Data presented here not only confirm the increased production of TNF-a, IL-8, and IL-1 by keratinocytes upon stimulation with P. acnes, but also demonstrated the involvement of p38a MAPK in this process.
Moreover, the biopsies from clinically diagnosed inflammatory acne lesions showed a marked increase of phospho-p38 nuclear staining in follicular and perifollicular epidermal keratinocytes, suggesting translocation of activated p38 to the nuclei. The finding is similar to the localization of activated NK-jB and activator protein-1 (AP-1) in inflammatory acne lesions [17] . The proliferative effect could be due to the ability of P. acnes to activate p38 by stabilizing IL-8 mRNA, and subsequently to upregulate IL-8 secretion resulting in keratinocyte proliferation [52] [53] [54] [55] . Both live and heat-killed P. acnes can induce phosphorylation of heat shock protein 27, a downstream cellular stress mediator of p38 [26] . Although our study only focused on acne lesional skin and non-lesional healthy skin, previous studies have reported that non- 
